Literature DB >> 20961389

The I4895T mutation in the type 1 ryanodine receptor induces fiber-type specific alterations in skeletal muscle that mimic premature aging.

Simona Boncompagni1, Ryan E Loy, Robert T Dirksen, Clara Franzini-Armstrong.   

Abstract

The I4898T (IT) mutation in type 1 ryanodine receptor (RyR1), the Ca(2+) release channel of the sarcoplasmic reticulum (SR) is linked to a form of central core disease (CCD) in humans and results in a nonleaky channel and excitation-contraction uncoupling. We characterized age-dependent and fiber-type-dependent alterations in muscle ultrastructure, as well as the magnitude and spatiotemporal properties of evoked Ca(2+) release in heterozygous Ryr1(I4895T/WT) (IT/+) knock-in mice on a mixed genetic background. The results indicate a classical but mild CCD phenotype that includes muscle weakness and the presence of mitochondrial-deficient areas in type I fibers. Electrically evoked Ca(2+) release is significantly reduced in single flexor digitorum brevis (FDB) fibers from young and old IT/+ mice. Structural changes are strongly fiber-type specific, affecting type I and IIB/IIX fibers in very distinct ways, and sparing type IIA fibers. Ultrastructural alterations in our IT/+ mice are also present in wild type, but at a lower frequency and older ages, suggesting that the disease mutation on the mixed background promotes an acceleration of normal age-dependent changes. The observed functional and structural alterations and their similarity to age-associated changes are entirely consistent with the known properties of the mutated channel, which result in reduced calcium release as is also observed in normal aging muscle. In strong contrast to these observations, a subset of patients with the analogous human heterozygous mutation and IT/+ mice on an inbred 129S2/SvPasCrl background exhibit a more severe disease phenotype, which is not directly consistent with the mutated channel properties.
© 2010 The Authors. Aging Cell © 2010 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961389      PMCID: PMC2980556          DOI: 10.1111/j.1474-9726.2010.00623.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  42 in total

Review 1.  Altered ryanodine receptor function in central core disease: leaky or uncoupled Ca(2+) release channels?

Authors:  Robert T Dirksen; Guillermo Avila
Journal:  Trends Cardiovasc Med       Date:  2002-07       Impact factor: 6.677

2.  Central core disease-an investigation of a rare muscle cell abnormality.

Authors:  W K ENGEL; J B FOSTER; B P HUGHES; H E HUXLEY; R MAHLER
Journal:  Brain       Date:  1961-06       Impact factor: 13.501

3.  Myogenic and neurogenic contributions to the development of fast and slow twitch muscles in rat.

Authors:  N A Rubinstein; A M Kelly
Journal:  Dev Biol       Date:  1978-02       Impact factor: 3.582

4.  A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.

Authors:  P J Lynch; J Tong; M Lehane; A Mallet; L Giblin; J J Heffron; P Vaughan; G Zafra; D H MacLennan; T V McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.

Authors:  Mihail G Chelu; Sanjeewa A Goonasekera; William J Durham; Wei Tang; John D Lueck; Joyce Riehl; Isaac N Pessah; Pumin Zhang; Meenakshi B Bhattacharjee; Robert T Dirksen; Susan L Hamilton
Journal:  FASEB J       Date:  2005-11-11       Impact factor: 5.191

6.  Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor.

Authors:  N Monnier; N B Romero; J Lerale; P Landrieu; Y Nivoche; M Fardeau; J Lunardi
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

7.  Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods.

Authors:  Elena Zvaritch; Natasha Kraeva; Eric Bombardier; Robert A McCloy; Frederic Depreux; Douglas Holmyard; Alexander Kraev; Christine E Seidman; J G Seidman; A Russell Tupling; David H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-03       Impact factor: 11.205

8.  LIGHT AND ELECTRON MICROSCOPIC STUDIES OF "MYOGRANULES" IN A CHILD WITH HYPOTONIA AND MUSCLE WEAKNESS.

Authors:  P E CONEN; E G MURPHY; W L DONOHUE
Journal:  Can Med Assoc J       Date:  1963-11-09       Impact factor: 8.262

9.  Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.

Authors:  Robert T Dirksen; Guillermo Avila
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

10.  RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice.

Authors:  William J Durham; Paula Aracena-Parks; Cheng Long; Ann E Rossi; Sanjeewa A Goonasekera; Simona Boncompagni; Daniel L Galvan; Charles P Gilman; Mariah R Baker; Natalia Shirokova; Feliciano Protasi; Robert Dirksen; Susan L Hamilton
Journal:  Cell       Date:  2008-04-04       Impact factor: 41.582

View more
  31 in total

1.  Novel details of calsequestrin gel conformation in situ.

Authors:  Stefano Perni; Matthew Close; Clara Franzini-Armstrong
Journal:  J Biol Chem       Date:  2013-09-11       Impact factor: 5.157

2.  CIR-Myo News: Proceedings of the 2014 Spring Padua Muscle Days: Terme Euganee and Padova (Italy), April 3-5, 2014.

Authors: 
Journal:  Eur J Transl Myol       Date:  2014-03-27

3.  Elongated mitochondrial constrictions and fission in muscle fatigue.

Authors:  Manuela Lavorato; Emanuele Loro; Valentina Debattisti; Tejvir S Khurana; Clara Franzini-Armstrong
Journal:  J Cell Sci       Date:  2018-12-05       Impact factor: 5.285

4.  Sequential stages in the age-dependent gradual formation and accumulation of tubular aggregates in fast twitch muscle fibers: SERCA and calsequestrin involvement.

Authors:  Simona Boncompagni; Feliciano Protasi; Clara Franzini-Armstrong
Journal:  Age (Dordr)       Date:  2011-02-12

5.  Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype.

Authors:  Valerie De Crescenzo; Kevin E Fogarty; Jason J Lefkowitz; Karl D Bellve; Elena Zvaritch; David H MacLennan; John V Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

6.  Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage.

Authors:  Benjamin Yuen; Simona Boncompagni; Wei Feng; Tianzhong Yang; Jose R Lopez; Klaus I Matthaei; Samuel R Goth; Feliciano Protasi; Clara Franzini-Armstrong; Paul D Allen; Isaac N Pessah
Journal:  FASEB J       Date:  2011-11-30       Impact factor: 5.191

7.  Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.

Authors:  Romain Lefebvre; Claude Legrand; Estela González-Rodríguez; Linda Groom; Robert T Dirksen; Vincent Jacquemond
Journal:  J Physiol       Date:  2011-10-03       Impact factor: 5.182

8.  Dyad content is reduced in cardiac myocytes of mice with impaired calmodulin regulation of RyR2.

Authors:  Manuela Lavorato; Tai-Qin Huang; Venkat Ramesh Iyer; Stefano Perni; Gerhard Meissner; Clara Franzini-Armstrong
Journal:  J Muscle Res Cell Motil       Date:  2015-02-19       Impact factor: 2.698

9.  Pathological mechanisms of vacuolar aggregate myopathy arising from a Casq1 mutation.

Authors:  Amy D Hanna; Chang Seok Lee; Lyle Babcock; Hui Wang; Joseph Recio; Susan L Hamilton
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.191

Review 10.  The disorders of the calcium release unit of skeletal muscles: what have we learned from mouse models?

Authors:  Marta Canato; Paola Capitanio; Carlo Reggiani; Lina Cancellara
Journal:  J Muscle Res Cell Motil       Date:  2014-11-26       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.